CDC invests in tech-enabled healthcare company mPharma
mPharma, a tech-enabled healthcare company developing a more efficient supply chain for pharmaceutical products across Africa, has completed a $17 million fundraising round, according to Quartz report.
The investment round was led by Novastar Ventures with participation from the CDC Group alongside other previous investors.
"Grateful to our investors for their continuous support. Honoured to welcome the CDC Group plc as a shareholder in mPharma as they make their first investment through their Catalyst Fund. Thankful to Novastar Ventures for leading the round," said mPharma CEO Gregory Rockson in a LinkedIn post.
Reach Africa’s private equity community by publishing a Showcase Article on Africa Private Equity News. Contact us at editor@africaprivateequitynews.com for our rate card and more information.